News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Trevor Page

Advertisement

Trevor Page is Group Technical Director at GEA Pharma Systems.

Articles by Trevor Page

Continuous Manufacturing—the Future of Pharmaceutical Manufacturing

ByTrevor Page
August 1st 2014

Continuous manufacturing is key to the future of pharmaceutical manufacturing.

Through-Vial Impedance Spectroscopy: A New In-Line Process Analytical Technology for Freeze Drying

ByGeoff Smith,Muhammad Sohail Arshad,Julian Taylor,Irina Ermolina,Eugene Polygalov,Kazem Nazari,Trevor Page
April 2nd 2014

A new process analytical technology based on impedance spectroscopy has potential applications for characterizing product attributes during the freeze-drying process.

Advertisement

Latest Updated Articles

  • Through-Vial Impedance Spectroscopy: A New In-Line Process Analytical Technology for Freeze Drying
    Through-Vial Impedance Spectroscopy: A New In-Line Process Analytical Technology for Freeze Drying

    Published: April 2nd 2014 | Updated:

  • Continuous Manufacturing—the Future of Pharmaceutical Manufacturing
    Continuous Manufacturing—the Future of Pharmaceutical Manufacturing

    Published: August 1st 2014 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor

2

Momentum and Automation Driving Pharma Innovation and Digitalization Through 2026

3

De-risking Biologic Development: Engineering Flexibility from Early Development to Launch

4

Accelerating HTA Readiness with Generative AI

5

Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us